
We are growing as a specialty pharmaceutical firm with a global presence by focusing on the development of new world-class drugs in selected therapeutic fields. In diagnostics, management resources are concentrated on products with strong growth prospects.
| Toshio Asano | President & Representative Director Presidential Executive Officer |
|---|---|
| Kazuyoshi Hori | Director Primary Executive Officer |
| Katsuto Motoda | Director Executive Officer |
| Yutaka Shibata | Director |
| Tadashi Nagatani | Executive Officer |
| Masayasu Shimadu | Executive Officer |
| Katsunori Horikoshi | Corporate Auditor |
| Seiji Nakano | Corporate Auditor |
(as of April 1, 2013)